GNMX

Aevi Genomic Medicine, Inc.CIK 1138776 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for GNMX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for GNMX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
McInaw Michael	Interim CFO	7	$0	$0	2020-02-03
Bayley Matthew D	Director	5	$0	$0	2020-02-03
Children's Hospital of Philadelphia Foundation	10% Owner	4	$2.45M	$0	2020-02-03
NEIL GARRY ARTHUR	Chief Scientific Officer	18	$360.9K	$0	2020-02-03
Duncan Barbara Gayle	Director	11	$75.0K	$0	2020-02-03
GRANO JOSEPH J JR	Director	18	$128.9K	$0	2020-02-03
CLEMOW ALASTAIR J	Director	17	$25.0K	$0	2020-02-03
BARER SOL J	Director	24	$3.29M	$532.8K	2020-02-03
BAUER EUGENE A	Director	13	$25.0K	$0	2020-02-03
COLA MICHAEL F	President and CEO	18	$416.4K	$0	2020-02-03
MedImmune Ltd	10% Owner	1	$0	$0	2019-12-19
Piper Brian	Chief Financial Officer	5	$0	$0	2018-06-14
GANTZ WILBUR H	Director	3	$50.0K	$0	2017-10-17
HARPER PHILIP R	10% Owner	6	$1.92M	$0	2017-08-23

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	100,000	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	900,000	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	13,532	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	200,000	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	261,000	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	300,000	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	13,334	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	200,000	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer deriv	2020-02-03	2020-02-05	200,000	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	1,500,000	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	661,000	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	450,000	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	21,181	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	250,000	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	292,087	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	17,327	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer deriv	2020-02-03	2020-02-05	250,000	—	$0	0	SEC↗
Children's Hospital of Philade	10% Owner	D To issuer deriv	2020-02-03	2020-02-05	2,824,217	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	15,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	3,530	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	15,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	12,857	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	15,000	—	$0	0	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer deriv	2020-02-03	2020-02-05	12,857	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer deriv	2020-02-03	2020-02-05	3,530	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer deriv	2020-02-03	2020-02-05	28,571	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer deriv	2020-02-03	2020-02-05	7,061	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer deriv	2020-02-03	2020-02-05	15,000	—	$0	0	SEC↗
Bayley Matthew D	Director	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
Bayley Matthew D	Director	D To issuer deriv	2020-02-03	2020-02-05	40,000	—	$0	0	SEC↗
Duncan Barbara Gayle	Director	D To issuer deriv	2020-02-03	2020-02-05	50,000	—	$0	0	SEC↗
Duncan Barbara Gayle	Director	D To issuer deriv	2020-02-03	2020-02-05	10,591	—	$0	0	SEC↗
Duncan Barbara Gayle	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
Duncan Barbara Gayle	Director	D To issuer deriv	2020-02-03	2020-02-05	20,000	—	$0	0	SEC↗
Duncan Barbara Gayle	Director	D To issuer deriv	2020-02-03	2020-02-05	40,000	—	$0	0	SEC↗
McInaw Michael	Interim CFO	D To issuer deriv	2020-02-03	2020-02-05	1,500	—	$0	0	SEC↗
McInaw Michael	Interim CFO	D To issuer deriv	2020-02-03	2020-02-05	6,500	—	$0	0	SEC↗
McInaw Michael	Interim CFO	D To issuer deriv	2020-02-03	2020-02-05	6,500	—	$0	0	SEC↗
McInaw Michael	Interim CFO	D To issuer deriv	2020-02-03	2020-02-05	5,000	—	$0	0	SEC↗
McInaw Michael	Interim CFO	D To issuer deriv	2020-02-03	2020-02-05	5,000	—	$0	0	SEC↗
McInaw Michael	Interim CFO	D To issuer deriv	2020-02-03	2020-02-05	26,250	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	15,000	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	200,000	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	200,000	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	100,000	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	80,000	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	80,000	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	80,000	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	74,912	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2020-02-03	2020-02-05	15,000	—	$0	0	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	D To issuer	2020-02-03	2020-02-05	2,164,150	—	$0	0	SEC↗
COLA MICHAEL F	President and CEO	D To issuer	2020-02-03	2020-02-05	2,267,859	—	$0	0	SEC↗
Children's Hospital of Philade	10% Owner	J Other	2020-02-03	2020-02-05	57,280,927	—	$0	0	SEC↗
Children's Hospital of Philade	10% Owner	J Other	2020-02-03	2020-02-05	38,856,891	—	$0	57,280,927	SEC↗
CLEMOW ALASTAIR J	Director	D To issuer	2020-02-03	2020-02-05	57,536	—	$0	0	SEC↗
BAUER EUGENE A	Director	D To issuer	2020-02-03	2020-02-05	165,715	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer	2020-02-03	2020-02-05	56,780	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer	2020-02-03	2020-02-05	27,000	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer	2020-02-03	2020-02-05	75,683	—	$0	0	SEC↗
GRANO JOSEPH J JR	Director	D To issuer	2020-02-03	2020-02-05	15,384	—	$0	0	SEC↗
Duncan Barbara Gayle	Director	D To issuer	2020-02-03	2020-02-05	59,524	—	$0	0	SEC↗
McInaw Michael	Interim CFO	D To issuer	2020-02-03	2020-02-05	16,107	—	$0	16,107	SEC↗
MedImmune Ltd	10% Owner	P Buy	2019-12-19	2020-02-07	12,946,900	—	$0	12,946,900	SEC↗
BARER SOL J	Director	J Other	2019-12-05	2019-12-09	2,551,020	—	$0	4,098,752	SEC↗
BARER SOL J	Director	S Sale	2019-12-05	2019-12-09	4,098,752	$0.13	$532.8K	0	SEC↗
BARER SOL J	Director	G Gift	2019-12-05	2019-12-09	365,854	—	$0	1,547,732	SEC↗
BARER SOL J	Director	J Other	2019-12-05	2019-12-09	2,551,020	—	$0	0	SEC↗
BARER SOL J	Director	G Gift	2019-12-05	2019-12-09	153,846	—	$0	0	SEC↗
BARER SOL J	Director	G Gift	2019-12-05	2019-12-09	365,854	—	$0	0	SEC↗
BARER SOL J	Director	G Gift	2019-12-05	2019-12-09	153,846	—	$0	1,181,878	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	P Buy	2019-12-05	2019-12-09	2,049,376	$0.13	$266.4K	2,164,150	SEC↗
COLA MICHAEL F	President and CEO	P Buy	2019-12-05	2019-12-09	2,049,376	$0.13	$266.4K	2,267,859	SEC↗
GRANO JOSEPH J JR	Director	P Buy	2018-11-07	2018-11-13	26,000	$1.16	$30.2K	75,683	SEC↗
GRANO JOSEPH J JR	Director	P Buy	2018-11-07	2018-11-13	21,000	$1.17	$24.6K	27,000	SEC↗
GRANO JOSEPH J JR	Director	P Buy	2018-11-07	2018-11-13	21,000	$1.15	$24.1K	56,780	SEC↗
Children's Hospital of Philade	10% Owner	P Buy	2018-08-15	2018-08-17	2,551,020	$0.96	$2.45M	18,424,036	SEC↗
BARER SOL J	Director	P Buy	2018-08-15	2018-08-17	2,551,020	$0.96	$2.45M	2,551,020	SEC↗
Duncan Barbara Gayle	Director	A Award deriv	2018-06-14	2018-07-18	50,000	—	$0	50,000	SEC↗
CLEMOW ALASTAIR J	Director	A Award deriv	2018-06-14	2018-07-18	50,000	—	$0	50,000	SEC↗
BAUER EUGENE A	Director	A Award deriv	2018-06-14	2018-07-18	50,000	—	$0	50,000	SEC↗
BARER SOL J	Director	A Award deriv	2018-06-14	2018-07-18	100,000	—	$0	100,000	SEC↗
GRANO JOSEPH J JR	Director	A Award deriv	2018-06-14	2018-07-18	50,000	—	$0	50,000	SEC↗
Bayley Matthew D	Director	A Award deriv	2018-06-14	2018-07-18	50,000	—	$0	50,000	SEC↗
Duncan Barbara Gayle	Director	A Award deriv	2018-06-14	2018-06-18	50,000	—	$0	50,000	SEC↗
CLEMOW ALASTAIR J	Director	A Award deriv	2018-06-14	2018-06-18	50,000	—	$0	50,000	SEC↗
BAUER EUGENE A	Director	A Award deriv	2018-06-14	2018-06-18	50,000	—	$0	50,000	SEC↗
BARER SOL J	Director	A Award deriv	2018-06-14	2018-06-18	100,000	—	$0	100,000	SEC↗
GRANO JOSEPH J JR	Director	A Award deriv	2018-06-14	2018-06-18	50,000	—	$0	50,000	SEC↗
Piper Brian	CFO & Corporate Secretary	A Award deriv	2018-06-14	2018-06-18	238,000	—	$0	238,000	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	A Award deriv	2018-06-14	2018-06-18	261,000	—	$0	261,000	SEC↗
COLA MICHAEL F	President and CEO	A Award deriv	2018-06-14	2018-06-18	661,000	—	$0	661,000	SEC↗
Bayley Matthew D	Director	A Award deriv	2018-06-14	2018-06-19	50,000	—	$0	50,000	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	A Award deriv	2018-05-14	2018-05-16	300,000	—	$0	300,000	SEC↗
COLA MICHAEL F	President and CEO	A Award deriv	2018-05-14	2018-05-16	450,000	—	$0	450,000	SEC↗
Piper Brian	CFO & Corporate Secretary	A Award deriv	2018-05-14	2018-05-16	270,000	—	$0	270,000	SEC↗
Bayley Matthew D	Director	A Award deriv	2017-12-04	2017-12-04	40,000	—	$0	40,000	SEC↗
BARER SOL J	Director	P Buy deriv	2017-10-17	2017-10-18	74,912	—	$0	74,912	SEC↗
GRANO JOSEPH J JR	Director	P Buy deriv	2017-10-17	2017-10-18	7,061	—	$0	7,061	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	P Buy deriv	2017-10-17	2017-10-18	13,344	—	$0	13,344	SEC↗
GANTZ WILBUR H	Director	P Buy deriv	2017-10-17	2017-10-18	7,061	—	$0	7,061	SEC↗
Duncan Barbara Gayle	Director	P Buy deriv	2017-10-17	2017-10-18	10,591	—	$0	10,591	SEC↗
CLEMOW ALASTAIR J	Director	P Buy deriv	2017-10-17	2017-10-18	3,530	—	$0	3,530	SEC↗
BAUER EUGENE A	Director	P Buy deriv	2017-10-17	2017-10-18	3,530	—	$0	3,530	SEC↗
COLA MICHAEL F	President and CEO	P Buy deriv	2017-10-17	2017-10-18	21,181	—	$0	21,181	SEC↗
BARER SOL J	Director	P Buy	2017-10-17	2017-10-18	421,032	$1.26	$530.5K	1,028,032	SEC↗
GRANO JOSEPH J JR	Director	P Buy	2017-10-17	2017-10-18	39,683	$1.26	$50.0K	98,463	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	P Buy	2017-10-17	2017-10-18	75,000	$1.26	$94.5K	114,774	SEC↗
GANTZ WILBUR H	Director	P Buy	2017-10-17	2017-10-18	39,683	$1.26	$50.0K	71,073	SEC↗
Duncan Barbara Gayle	Director	P Buy	2017-10-17	2017-10-18	59,524	$1.26	$75.0K	59,524	SEC↗
CLEMOW ALASTAIR J	Director	P Buy	2017-10-17	2017-10-18	19,841	$1.26	$25.0K	57,536	SEC↗
BAUER EUGENE A	Director	P Buy	2017-10-17	2017-10-18	19,841	$1.26	$25.0K	165,715	SEC↗
COLA MICHAEL F	President and CEO	P Buy	2017-10-17	2017-10-18	119,047	$1.26	$150.0K	218,483	SEC↗
HARPER PHILIP R	10% Owner	P Buy	2017-08-23	2017-08-24	5,700	$1.20	$6.8K	4,876,044	SEC↗
HARPER PHILIP R	10% Owner	P Buy	2017-08-22	2017-08-24	4,661	$1.20	$5.6K	4,870,344	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	A Award deriv	2017-08-11	2018-05-16	100,000	—	$0	100,000	SEC↗
COLA MICHAEL F	President and CEO	A Award deriv	2017-08-11	2018-05-16	50,000	—	$0	50,000	SEC↗
Piper Brian	CFO & Corporate Secretary	A Award deriv	2017-08-11	2018-05-16	110,000	—	$0	110,000	SEC↗
COLA MICHAEL F	President and CEO	A Award deriv	2017-08-11	2017-08-15	500,000	—	$0	500,000	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	A Award deriv	2017-08-11	2017-08-15	400,000	—	$0	400,000	SEC↗
Piper Brian	CFO and Corporate Secretary	A Award deriv	2017-08-11	2017-08-15	380,000	—	$0	380,000	SEC↗
HARPER PHILIP R	10% Owner	P Buy	2017-08-10	2017-08-14	20,470	$1.19	$24.4K	4,865,683	SEC↗
BAUER EUGENE A	Director	A Award deriv	2017-06-22	2017-08-10	20,000	—	$0	20,000	SEC↗
CLEMOW ALASTAIR J	Director	A Award deriv	2017-06-22	2017-08-10	20,000	—	$0	20,000	SEC↗
Duncan Barbara Gayle	Director	A Award deriv	2017-06-22	2017-08-10	20,000	—	$0	20,000	SEC↗
GANTZ WILBUR H	Director	A Award deriv	2017-06-22	2017-08-10	20,000	—	$0	20,000	SEC↗
GRANO JOSEPH J JR	Director	A Award deriv	2017-06-22	2017-08-10	20,000	—	$0	20,000	SEC↗
BARER SOL J	Director	A Award deriv	2017-06-22	2017-08-10	80,000	—	$0	80,000	SEC↗
BARER SOL J	Director	P Buy	2017-04-28	2017-05-01	100,000	$1.57	$157.0K	607,000	SEC↗
BARER SOL J	Director	P Buy	2017-04-26	2017-04-27	100,000	$1.54	$154.0K	507,000	SEC↗
HARPER PHILIP R	10% Owner	P Buy	2017-03-24	2017-03-27	53,826	$1.60	$86.1K	4,845,213	SEC↗
HARPER PHILIP R	10% Owner	P Buy	2017-03-23	2017-03-27	4,705	$1.60	$7.5K	4,791,387	SEC↗
HARPER PHILIP R	10% Owner	P Buy	2017-03-22	2017-03-27	1,000,000	$1.79	$1.79M	4,786,682	SEC↗
Piper Brian	Chief Financial Officer	A Award deriv	2017-02-17	2017-02-17	190,000	—	$0	190,000	SEC↗
COLA MICHAEL F	President and CEO	A Award deriv	2017-02-17	2017-02-17	250,000	—	$0	250,000	SEC↗
NEIL GARRY ARTHUR	Chief Scientific Officer	A Award deriv	2017-02-17	2017-02-17	200,000	—	$0	200,000	SEC↗